Fas Ligand (CD95L) and Cancer Gene Therapy

被引：0
|
作者：
Gary J. Nabel
机构：
[1] National Institutes of Health,
[2] Vaccine Research Center,undefined
来源：
Nature Biotechnology | 1999年 / 17卷 / Suppl 4期
关键词：
D O I：
10.1038/70149
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 25
相关论文
共 50 条
  • [41] CD95 and CD95L promote and protect cancer stem cells
    Ceppi, Paolo
    Hadji, Abbas
    Kohlhapp, Frederick J.
    Pattanayak, Abhinandan
    Hau, Annika
    Liu, Xia
    Liu, Huiping
    Murmann, Andrea E.
    Peter, Marcus E.
    NATURE COMMUNICATIONS, 2014, 5
  • [42] CD95 and CD95L in gastrointestinal cancer patients peripheral blood
    Jaunalksne, Into
    Donina, Simona
    Engele, Ludmila
    Romanova, Tatjana
    CLINICAL IMMUNOLOGY, 2008, 127 : S146 - S146
  • [43] Heightened CD95 (Fas)-CD95L (Fas ligand) interactions and T cell apoptosis in stable cardiac transplant recipients: A potential mechanism for tolerance induction.
    Ankersmit, J
    Moser, B
    Hofmann, M
    Schuster, MD
    Karimova, A
    Wolf, I
    Hericis, R
    Grimm, M
    Kocher, AA
    Edwards, NM
    Wolner, E
    Itescu, S
    TRANSPLANTATION, 2000, 69 (08) : S250 - S250
  • [44] Immunohistochemical detection of CD95L (Fas Ligand) in mantle cell lymphoma: A prognostic factor for clinical outcome.
    Schrader, C
    Meusers, P
    Brittinger, G
    Janssen, D
    Parwaresch, R
    Kneba, M
    Tiemann, M
    BLOOD, 2004, 104 (11) : 225B - 226B
  • [45] CD95 and CD95L promote and protect cancer stem cells
    Paolo Ceppi
    Abbas Hadji
    Frederick J. Kohlhapp
    Abhinandan Pattanayak
    Annika Hau
    Xia Liu
    Huiping Liu
    Andrea E. Murmann
    Marcus E. Peter
    Nature Communications, 5
  • [46] Characterization of CD95 ligand (CD95L)-induced apoptosis in human tenon fibroblasts
    Hueber, A
    Welsandt, G
    Jordan, JF
    Mietz, H
    Weller, M
    Krieglstein, GK
    Esser, PJ
    EXPERIMENTAL EYE RESEARCH, 2002, 75 (01) : 1 - 8
  • [47] Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L
    Aragane, Y
    Kulms, D
    Metze, D
    Wilkes, G
    Pöppelmann, B
    Luger, TA
    Schwarz, T
    JOURNAL OF CELL BIOLOGY, 1998, 140 (01): : 171 - 182
  • [48] Trophoblast apoptosis in chorioamnionitis: Possible role for FasL (CD95L) and its receptor Fas (CD95)
    Balkundi, DR
    Ziegler, J
    Watchko, JF
    Trucco, M
    PEDIATRIC RESEARCH, 2002, 51 (04) : 57A - 57A
  • [49] Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma
    Blaes, Jonas
    Thome, Carina M.
    Pfenning, Philipp-Niclas
    Ruebmann, Petra
    Sahm, Felix
    Wick, Antje
    Bunse, Theresa
    Schmenger, Torsten
    Sykora, Jaromir
    von Deimling, Andreas
    Wiestler, Benedikt
    Merz, Christian
    Jugold, Manfred
    Haberkorn, Uwe
    Abdollahi, Amir
    Debus, Juergen
    Gieffers, Christian
    Kunz, Claudia
    Bendszus, Martin
    Kluge, Michael
    Platten, Michael
    Fricke, Harald
    Wick, Wolfgang
    Lemke, Dieter
    MOLECULAR CANCER RESEARCH, 2018, 16 (05) : 767 - 776
  • [50] Fas ligand (CD95L) expression in rejecting islet allografts in IL-2 knock out mice.
    Manfro, RC
    RoyChaudhury, P
    Zheng, XX
    Li, YS
    Tian, Y
    Strom, TB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3213 - A3213
12345